| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study (NCT05106608) | Universidad de Granada | 2022-07-13 |
| Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. (NCT06321640) | European Institute of Oncology | 2022-07-08 |
| Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies (NCT05226871) | Pfizer | 2022-07-07 |
| Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients (NCT05607225) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-07-01 |
| SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes (NCT05754814) | Rigshospitalet, Denmark | 2022-06-28 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome (NCT05400239) | Guy's and St Thomas' NHS Foundation Trust | 2022-06-01 |
| Hospital Acquired Pneumonia in Temporary Tracheostomy (NCT05418517) | Guy's and St Thomas' NHS Foundation Trust | 2022-06-01 |
| The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers (NCT05483374) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-31 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| Training Swallowing Initiation During Expiration (NCT05278039) | Northwestern University | 2022-05-19 |
| Immune Biomarker Study for Head and Neck Cancer (NCT05375266) | University of Erlangen-Nürnberg Medical School | 2022-05-16 |
| Perioperative Nutritional Optimization in Head and Neck Cancer Patients (NCT04449445) | University of Illinois at Chicago | 2022-05-10 |
| Submandibular Gland Stem Cell Transplantation (NCT04593589) | University Medical Center Groningen | 2022-05-10 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal (NCT06152055) | Tribhuvan University, Nepal | 2022-05-01 |
| Safety and Efficacy of APG-157 in Head and Neck Cancer (NCT05312710) | Aveta Biomics, Inc. | 2022-04-22 |
| MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors (NCT05076760) | Memgen, Inc. | 2022-04-21 |
| The GOAL27-6 Study (NCT05859828) | East and North Hertfordshire NHS Trust | 2022-04-21 |
| FMISO-based Adaptive Radiotherapy for Head and Neck Cancer (NCT05348486) | University Hospital Olomouc | 2022-04-20 |
| ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases (NCT05265013) | Rakuten Medical, Inc. | 2022-04-19 |
| Big Data for Quality of Life in Head and Neck Cancer (NCT05315570) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-03-28 |
| Predicting Toxicity in Elderly Patients With Head and Neck Cancer (NCT06344208) | European Institute of Oncology | 2022-03-15 |
| Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (NCT05169437) | Tempus AI | 2022-03-15 |
| Comparing Two Ways to Manage Head and Neck Lymphedema (NCT05182229) | Abramson Cancer Center at Penn Medicine | 2022-03-11 |
| Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck (NCT04805528) | University of Rochester | 2022-03-10 |
| Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck (NCT05644457) | Royal Marsden NHS Foundation Trust | 2022-03-09 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy (NCT05273307) | University of California, San Francisco | 2022-03-04 |
| A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer (NCT04883281) | University of Texas Southwestern Medical Center | 2022-02-23 |
| Prehabilitation and Recovery After Head and Neck Cancer Surgery (NCT04598087) | University of Calgary | 2022-02-09 |
| Measurement of Head and Neck Tumor Hypoxia With PET-MRI (NCT05246475) | Turku University Hospital | 2022-02-08 |
| The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care (NCT04541381) | University of Chicago | 2022-02-07 |
| A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer (NCT05239000) | Memorial Sloan Kettering Cancer Center | 2022-02-03 |
| Photobiomodulation Home-use Device for Prevention or Treatment of Oral Mucositis in Patients With Head&Neck Malignancies (NCT05176834) | Erika Carmel ltd | 2022-01-31 |
| Circulating Immunes Cells, Cytokines and Brain Radiotherapy (NCT05082961) | Centre Francois Baclesse | 2022-01-27 |
| Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer (NCT05156060) | Natalie Lockney | 2022-01-24 |
| Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors (NCT05313191) | The New York Proton Center | 2022-01-24 |
| ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer (NCT05182866) | Rakuten Medical, Inc. | 2022-01-21 |
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) (NCT04938609) | Providence Health & Services | 2022-01-11 |
| The Management of RT-induced Hyposalivation Using LLLT (NCT05538169) | King Saud University | 2022-01-03 |
| Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer Patients (NCT04996641) | Abramson Cancer Center at Penn Medicine | 2022-01-03 |
| Effects of a Home-Based Exercise Program During Radiotherapy (NCT07376213) | Burak Ertürk | 2022-01-02 |
| Carotid Artery Stenosis and Ischemic Cerebrovascular Events After Radiotherapy in Patients With Head and Neck Cancer (NCT06556979) | Chulabhorn Royal Academy | 2022-01-01 |
| Prospective PROM and PREM Analysis Demonstrating Specification Advantage and Language Barriers (NCT06457594) | Hadassah Medical Organization | 2022-01-01 |
| Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI (NCT05160714) | University Hospital Tuebingen | 2022-01-01 |
| A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy (NCT05207098) | Memorial Sloan Kettering Cancer Center | 2021-12-22 |
| Benzydamine Oromucosal Solution in Oral Mucositis (BOOM) (NCT05055726) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2021-12-06 |
| Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study (NCT05180851) | Shanghai Fengxian District Central Hospital | 2021-11-30 |
| DOsimetry and Radiation Induced NAusea in Head and Neck Cancers (NCT06341985) | European Institute of Oncology | 2021-11-15 |
| A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer (NCT05539144) | Hebei Provincial Hospital of Traditional Chinese Medicine | 2021-11-11 |
| Monitoring Skeletal Muscle Mass Using CBCT in Patients With H&N Cancer Undergoing Chemoradiotherapy (NCT05126095) | Guangdong Provincial People's Hospital | 2021-11-03 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| İnvestigation of the Effect of Neck Endurance on Swallowing and Directional Coordination in Head and Neck Cancer Patients (NCT07434245) | Istanbul Arel University | 2021-11-01 |
| Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy (NCT06773039) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-10-28 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome (NCT05083416) | H. Lee Moffitt Cancer Center and Research Institute | 2021-10-20 |
| AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART) (NCT05081531) | Istituto Clinico Humanitas | 2021-10-05 |
| Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors (NCT04930432) | Betta Pharmaceuticals Co., Ltd. | 2021-09-24 |
| A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer (NCT05053230) | Memorial Sloan Kettering Cancer Center | 2021-09-20 |
| Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (NCT05060432) | iTeos Belgium SA | 2021-09-06 |
| Tumescence in HNC Skin Graft Reconstruction (NCT04967391) | University of California, Davis | 2021-09-01 |
| Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis (NCT05040425) | Chang Gung Memorial Hospital | 2021-08-30 |
| Low-Level Laser in Head and Neck Chronic Lymphedema (NCT04482855) | Abramson Cancer Center at Penn Medicine | 2021-08-19 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis (NCT05817617) | Centro di Riferimento Oncologico - Aviano | 2021-08-08 |
| RAPA-201 Therapy of Solid Tumors (NCT05144698) | Rapa Therapeutics LLC | 2021-08-01 |
| A Rehabilitation Education Care Program on Return to Work Among Head and Neck Cancer Survivors (NCT04322695) | Chang Gung University of Science and Technology | 2021-07-31 |
| A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors (NCT04801095) | Wellmarker Bio | 2021-07-14 |
| Trial of BMX-001 or Placebo in Head and Neck Cancer Patients (NCT04607642) | BioMimetix JV, LLC | 2021-07-01 |
| RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck (NCT04910308) | Oslo University Hospital | 2021-07-01 |
| DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase) (NCT04162431) | University of Exeter | 2021-06-28 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma (NCT04303975) | Jiarong Chen, MD | 2021-06-01 |
| Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis (NCT04671862) | Ottawa Hospital Research Institute | 2021-06-01 |
| AB122 Platform Study (NCT04999761) | Taiho Pharmaceutical Co., Ltd. | 2021-06-01 |
| A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma (NCT06879691) | Biotech Pharmaceutical Co., Ltd. | 2021-05-15 |
| Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) (NCT04675333) | ALX Oncology Inc. | 2021-05-10 |
| This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. (NCT05061940) | Repertoire Immune Medicines | 2021-05-05 |
| Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy (NCT04543045) | The Christie NHS Foundation Trust | 2021-05-05 |
| Navigation on Head and Neck Radiotherapy (NCT04857749) | Selcuk University | 2021-05-03 |
| Head and Neck cancERs International cOviD-19 collabOraTion (NCT04632173) | Hellenic Cooperative Oncology Group | 2021-05-03 |
| Quality of Life in Head and Neck Patients (NCT04853862) | University of Brasilia | 2021-05-01 |
| Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. (NCT04704453) | Institut Claudius Regaud | 2021-04-28 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| RTX-321 Monotherapy in Patients With HPV 16+ Tumors (NCT04672980) | Rubius Therapeutics | 2021-04-08 |
| Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (NCT04779151) | Gustave Roussy, Cancer Campus, Grand Paris | 2021-04-07 |
| Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site (NCT04880603) | Nebraska Methodist Health System | 2021-04-05 |
| Body Image After Head and Neck Cancer Treatment (NCT04830488) | Bethany Rhoten | 2021-04-05 |
| Phase II Panitumumab-IRDye800 in Head & Neck Cancer (NCT04511078) | University of Alabama at Birmingham | 2021-04-02 |
| Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) (NCT04675294) | ALX Oncology Inc. | 2021-04-02 |
| A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study (NCT04814069) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2021-04-01 |
| Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy (NCT04872517) | Liao Jian An | 2021-04-01 |
| Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features (NCT05865756) | Jules Bordet Institute | 2021-04-01 |
| Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer (NCT04840472) | Stanford University | 2021-03-30 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
| Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer (NCT04634825) | MacroGenics | 2021-03-17 |
| Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer (NCT04611113) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2021-03-17 |
| Early Feeding After Oral Cavity Reconstruction (NCT04787939) | Icahn School of Medicine at Mount Sinai | 2021-03-10 |